Skip to search formSkip to main contentSkip to account menu

Amphotericin B Colloidal Dispersion

Known as: AMPHOTERICIN B CHOLESTERYL SULFATE, Amphotericin B Colloidal Dispersion [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

28 relations
AIDS-Related Opportunistic InfectionsAmphotericin 100mg powder for infusion solution vialAmphotericin B Cholesterol DispersionAntifungal Agents

Broader (3)

Amphotericin BCholesterol Estersamphotericin B liposomal

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Amphotericin-B Colloidal Dispersion
SummaryAbstractFormulation of amphotericin B with sodium cholesteryl sulphate alters the pharmacokinetic properties of the drug… 
2006
2006
Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis.
BACKGROUND In Bihar, India, where visceral leishmaniasis (VL) is hyperendemic and refractory to antimony, amphotericin B is the… 
2005
2005
Comparison of the effect of amphotericin B desoxycholate and amphotericin B colloidal dispersion on renal functions and renal morphology in rats
Background and Aim:  Amphotericin B (AmB) desoxycholate remains as one of the most efficacious agents currently available for the… 
2004
2004
Influence of amphotericin B deoxycholate or amphotericin B colloidal dispersion on renal tubule epithelium in rat.
Amphotericin B deoxycholate (AmB) or Amphotericin B colloidal dispersion (ABCD) are used in clinics for the treatment of systemic… 
Review
1999
Review
1999
Treatment of Visceral Leishmaniasis with Amphotericin B Colloidal Dispersion
Amphotericin B is an effective antileishmanial agent whose use is limited by drug toxicity. The development of less toxic, lipid… 
Review
1999
Review
1999
Clinical Efficacy of Amphotericin B Colloidal Dispersion against Infections Caused by Aspergillus spp
Three published clinical trials of the efficacy of amphotericin B colloidal dispersion (ABCD) against infections caused by… 
Review
1999
Review
1999
Renal Sparing by Amphotericin B Colloidal Dispersion: Clinical Experience in 572 Patients
Data from five clinical trials of amphotericin B colloidal dispersion (ABCD) in the treatment of invasive mycoses were pooled to… 
Review
1999
Review
1999
Clinical Efficacy of Amphotericin B Colloidal Dispersion against Infections Caused by Candida spp
Five clinical trials of the efficacy of amphotericin B colloidal dispersion (ABCD) primarily in patients unable to tolerate or… 
Review
1998
Review
1998
The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.
PURPOSE/OBJECTIVES To review the drug profile and nursing implications associated with the new lipid amphotericin preparations… 
Review
1998
Review
1998
Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
UNLABELLED Formulation of amphotericin B with sodium cholesteryl sulphate alters the pharmacokinetic properties of the drug… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)